|
US4123403A
(en)
|
1977-06-27 |
1978-10-31 |
The Dow Chemical Company |
Continuous process for preparing aqueous polymer microsuspensions
|
|
US4502888A
(en)
|
1982-12-13 |
1985-03-05 |
The Dow Chemical Company |
Aqueous dispersions of plasticized polymer particles
|
|
US5643602A
(en)
*
|
1989-11-22 |
1997-07-01 |
Astra Aktiebolag |
Oral composition for the treatment of inflammatory bowel disease
|
|
SE8903914D0
(sv)
|
1989-11-22 |
1989-11-22 |
Draco Ab |
Oral composition for the treatment of inflammatory bowel diseases
|
|
DE69425453T2
(de)
|
1993-04-23 |
2001-04-12 |
Novartis Ag, Basel |
Wirkstoffabgabevorrichtung mit gesteuerter Freigabe
|
|
DE4332394A1
(de)
|
1993-09-23 |
1995-03-30 |
Falk Pharma Gmbh |
Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
|
|
US5482718A
(en)
*
|
1994-03-23 |
1996-01-09 |
Hoffmann-La Roche Inc. |
Colon-targeted delivery system
|
|
GB9412394D0
(en)
|
1994-06-21 |
1994-08-10 |
Danbiosyst Uk |
Colonic drug delivery composition
|
|
DE4446891A1
(de)
|
1994-12-27 |
1996-07-04 |
Falk Pharma Gmbh |
Stabile wäßrige Budesonid-Lösung
|
|
SG80553A1
(en)
|
1995-07-20 |
2001-05-22 |
Tanabe Seiyaku Co |
Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
|
|
GB9516268D0
(en)
|
1995-08-08 |
1995-10-11 |
Danbiosyst Uk |
Compositiion for enhanced uptake of polar drugs from the colon
|
|
GB9722426D0
(en)
|
1997-10-23 |
1997-12-24 |
Univ London Pharmacy |
Controlled release formulations
|
|
US6239120B1
(en)
|
1998-03-17 |
2001-05-29 |
Pharmalink Ab |
Method and means for treating glomerulonephritis
|
|
SE514128C2
(sv)
*
|
1998-03-17 |
2001-01-08 |
Pharmalink Ab |
Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
|
|
CA2377301C
(en)
|
1999-06-14 |
2009-05-12 |
Cosmo S.P.A. |
Controlled release and taste masking oral pharmaceutical compositions
|
|
US8895064B2
(en)
*
|
1999-06-14 |
2014-11-25 |
Cosmo Technologies Limited |
Controlled release and taste masking oral pharmaceutical composition
|
|
DE10004939C1
(de)
|
2000-02-05 |
2001-08-23 |
Lothar Moerl |
Steuerbare Gasanströmeinrichtung für Strahlschichtapparate
|
|
DE10013029A1
(de)
|
2000-03-17 |
2001-09-20 |
Roehm Gmbh |
Mehrschichtige Arzneiform für die Colonfreigabe
|
|
ITRM20010614A1
(it)
|
2001-10-16 |
2003-04-16 |
Italchimici S P A |
Preparazione farmaceutica di una soluzione idro/propilenica di budesonide e suo procedimento di preparazione.
|
|
DE10162781A1
(de)
|
2001-12-20 |
2003-07-03 |
Glatt Ingtech Gmbh |
Strahlschichtapparat zur chargenweisen oder kontinuierlichen Prozessführung und Verfahren zum Betreiben eines Strahlschichtapparates
|
|
DE10214002A1
(de)
|
2002-03-27 |
2003-10-09 |
Roehm Gmbh |
Pharmazeutische Formulierung für den Wirkstoff Budesonid
|
|
DE10250543A1
(de)
|
2002-10-29 |
2004-05-19 |
Röhm GmbH & Co. KG |
Mehrschichtige Arzneiform
|
|
WO2004052607A1
(en)
|
2002-12-10 |
2004-06-24 |
Cps Orocel Llc |
Method of preparing biologically active formulations
|
|
DE10322062A1
(de)
|
2003-05-15 |
2004-12-02 |
Glatt Ingenieurtechnik Gmbh |
Verfahren und Vorrichtung zum Aufbringen von Flüssigkeiten in eine Feststoffströmung eines Strahlschichtapparates
|
|
DE10325989A1
(de)
|
2003-06-07 |
2005-01-05 |
Glatt Gmbh |
Verfahren zur Herstellung von und daraus resultierende Mikropellets sowie deren Verwendung
|
|
AR041873A1
(es)
|
2003-10-30 |
2005-06-01 |
Pablo Cassara Srl Lab |
Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
|
|
DE102004043863A1
(de)
|
2004-09-10 |
2006-03-16 |
Nitec Pharma Ag |
Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum
|
|
DE102005037630A1
(de)
|
2005-08-09 |
2007-02-15 |
Glatt Gmbh |
Verfahren zur Herstellung von Teilchen aus pharmazeutischen Substanzen, Teilchen aus pharmazeutischen Substanzen sowie deren Verwendung
|
|
DE102005060393A1
(de)
|
2005-12-16 |
2007-06-21 |
Add Advanced Drug Delivery Technologies Ltd. |
Orales Präparat mit kontrollierter Freisetzung
|
|
CN101108171A
(zh)
|
2006-07-17 |
2008-01-23 |
复旦大学 |
一种布地奈德肠溶缓释微丸及其制备方法
|
|
EP2002835A1
(en)
|
2007-06-04 |
2008-12-17 |
GenKyo Tex |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
|
US20090004281A1
(en)
|
2007-06-26 |
2009-01-01 |
Biovail Laboratories International S.R.L. |
Multiparticulate osmotic delivery system
|
|
JP2011506607A
(ja)
|
2007-12-17 |
2011-03-03 |
ザリカス インコーポレイティッド |
免疫炎症性障害の処置のための治療法
|
|
GB0808537D0
(en)
*
|
2008-05-12 |
2008-06-18 |
Archimedes Dev Ltd |
Compositions
|
|
EP2166010A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
|
EP2166008A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
|
EP2166009A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as nadph oxidase inhibitors
|
|
EP2165707A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
|
US8945616B2
(en)
*
|
2009-02-17 |
2015-02-03 |
Mylan Pharmaceuticals Inc. |
Controlled release budesonide minitablets
|
|
NZ599933A
(en)
|
2009-11-03 |
2014-08-29 |
Lipidor Ab |
Lipid layer forming composition for administration onto a surface of a living organism
|
|
JP2014510064A
(ja)
|
2011-02-25 |
2014-04-24 |
ザ ジョンズ ホプキンス ユニバーシティ |
Ｎｒｆ２活性剤としてのカルコン誘導体
|
|
AU2012251135A1
(en)
|
2011-05-02 |
2013-11-07 |
Lipidor Ab |
Treatment of psoriasis
|
|
US10034943B2
(en)
|
2011-05-02 |
2018-07-31 |
Lipidor Ab |
Sprayable topical carrier and composition comprising phosphatidylcholine
|
|
EP2591782A1
(en)
|
2011-11-11 |
2013-05-15 |
Johann Wolfgang Goethe-Universität |
Nadph oxidase 4 inhibitors and use thereof
|
|
WO2013078261A1
(en)
|
2011-11-22 |
2013-05-30 |
The University Of Maryland, Baltimore |
Treatment of muscular conditions and muscular dystrophies
|
|
EP2857399A1
(en)
|
2013-10-03 |
2015-04-08 |
GenKyoTex SA |
Compounds useful for the treatment of PDE5 inhibitor-poorly responsive erectile dysfunction
|
|
IN2013MU03373A
(enExample)
|
2013-10-25 |
2015-07-17 |
Cadila Healthcare Ltd |
|
|
WO2015071812A1
(en)
|
2013-11-18 |
2015-05-21 |
Wockhardt Limited |
Solid oral modified-release composition comprising budesonide or salt thereof
|
|
GB201419257D0
(en)
|
2014-10-29 |
2014-12-10 |
Jagotec Ag |
Pharmaceutical compositions
|
|
EP3034500A1
(en)
|
2014-12-17 |
2016-06-22 |
Genkyotex Sa |
Amido thiazole derivatives as NADPH oxidase inhibitors
|
|
US20190125678A1
(en)
|
2015-01-30 |
2019-05-02 |
Mylan, Inc. |
Sustained-Release Oral Dosage Forms for Low Aqueous Solubility Compounds
|
|
EP3098220A1
(en)
|
2015-05-28 |
2016-11-30 |
GenKyoTex SA |
Process for the preparation of a nadph oxidase inhibitor and its polymorphs and uses thereof
|
|
US9707182B2
(en)
|
2015-09-11 |
2017-07-18 |
Sun Pharmaceutical Industries Ltd. |
Oral pharmaceutical dosage forms of budesonide
|
|
AR106330A1
(es)
|
2015-10-13 |
2018-01-03 |
Flexion Therapeutics Inc |
Formulaciones de corticoesteroide para mantener las concentraciones de corticoesteroide en líquido sinovial
|
|
CN105663091A
(zh)
|
2016-01-28 |
2016-06-15 |
上海信谊百路达药业有限公司 |
一种布地奈德肠溶缓释胶囊及其制备方法
|
|
US11590084B2
(en)
|
2016-05-02 |
2023-02-28 |
Roman Bielski |
Microcapsules for controlled delivery of an active pharmaceutical ingredient
|
|
US10286036B2
(en)
|
2017-05-12 |
2019-05-14 |
Aurinia Pharmaceuticals Inc. |
Protocol for treatment of lupus nephritis
|
|
EP3479843A1
(en)
|
2017-11-01 |
2019-05-08 |
GenKyoTex Suisse SA |
Use of nox inhibitors for treatment of cancer
|
|
CA3091443A1
(en)
|
2018-02-22 |
2019-08-29 |
Avior, Inc. |
Transmucosal film composition and methods of making and using the same
|
|
EP3553081A1
(en)
|
2018-04-12 |
2019-10-16 |
Bayer Aktiengesellschaft |
Atrial natriuretic peptide engrafted antibodies
|
|
WO2020011938A1
(en)
|
2018-07-11 |
2020-01-16 |
Medizinische Universität Wien |
Glucocorticoids for the topical treatment of autoimmune gastritis
|
|
EP3628669A1
(en)
|
2018-09-28 |
2020-04-01 |
GenKyoTex Suisse SA |
Novel compounds as nadph oxidase inhibitors
|
|
CN110507627B
(zh)
|
2019-09-29 |
2021-11-02 |
重庆医药高等专科学校 |
一种布地奈德的口服控释药物组合物
|
|
WO2021127003A1
(en)
|
2019-12-16 |
2021-06-24 |
Children's Medical Center Corporation |
Treating heart disease in muscular dystrophy patients
|
|
CN112999229B
(zh)
|
2019-12-19 |
2023-01-24 |
江苏恒瑞医药股份有限公司 |
一种包含布地奈德的口服药物组合物
|
|
US20240197639A1
(en)
|
2021-04-20 |
2024-06-20 |
Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
Capsule for specific drug delivery and preparation method therefor
|
|
TW202302116A
(zh)
|
2021-04-20 |
2023-01-16 |
大陸商江蘇恒瑞醫藥股份有限公司 |
口服腸溶皮質類固醇的藥物組合物
|
|
CN115737597A
(zh)
|
2021-09-02 |
2023-03-07 |
江苏豪森药业集团有限公司 |
一种口服的肠溶速释药物组合物、制备方法及其应用
|
|
US11896719B2
(en)
*
|
2022-01-24 |
2024-02-13 |
Calliditas Therapeutics Ab |
Pharmaceutical compositions
|
|
US20240033225A1
(en)
*
|
2022-01-24 |
2024-02-01 |
Calliditas Therapeutics Ab |
Pharmaceutical compositions
|